ICUI ICU MEDICAL INC/DE

Q3 2025 10-Q

Filed: Nov 6, 2025Period ending Sep 30, 2025

Health Care

Surgical & Medical Instruments & ApparatusSEC EDGAR

ICU MEDICAL INC/DE (ICUI) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue and profitability details not disclosed in provided text
• No segment or product line performance data available

+2 more insights

Risk Factors

• Newly added risk: Sept 2025 U.S. Commerce Dept national security probe on medical imports under Section 232, potential additional tariffs on key products
• Most materially updated risk: July 31, 2025 tariff increase from 10% to 15% on imports from Costa Rica impacting supply chain costs

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$537M

▼ -8.9% YoY▼ -2.2% QoQ

Net Income

-$39M

▼ -234.6% YoY▼ -176.2% QoQ

Gross Margin

37.4%

▲ +264bp YoY▼ -50bp QoQ

Operating Margin

2.6%

▲ +116bp YoY▲ +63bp QoQ

Net Margin

-7.2%

▼ -525bp YoY▼ -1647bp QoQ

ROE

-1.8%

Total Assets

$4.1B

EPS (Diluted)

$-0.14

▲ +89.6% YoY▼ -109.8% QoQ

Operating Cash Flow

$57M

▲ +57.1% YoY▲ +405.8% QoQ

Source: XBRL data from ICU MEDICAL INC/DE Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on ICU MEDICAL INC/DE

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.